Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Shea

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2005
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignanciesDon A Gabriel, Thomas C Shea, Jonathan S Serody, et al.
Cancer|June 29, 2016
Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North CarolinaAshley T Freeman, Anne-Marie Meyer, Andrew B Smitherman, et al.
Leukemia & Lymphoma|August 5, 2011
A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphomaAnne W Beaven, Thomas C Shea, Dominic T Moore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD developmentYuri Fedoriw, T Danielle Samulski, Allison M Deal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple MyelomaAshley T Freeman, May Kuo, Lei Zhou, et al.
Clinical Therapeutics|October 25, 2016
Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/LPearlie P Chong, David van Duin, Ananta Bangdiwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation settingPatrick J Stiff, Christos Emmanouilides, William I Bensinger, et al.
Pathogens & Immunity|December 23, 2016
Increasing Rates of Fluoroquinolone Resistance in <i>Escherichia coli</i> Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant RecipientsChristopher G Hauck, Pearlie P Chong, Melissa B Miller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2020
Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantationZev M Nakamura, Allison M Deal, Donald L Rosenstein, et al.
Contemporary Clinical Trials|July 4, 2020
Design of a randomized placebo controlled trial of high dose intravenous thiamine for the prevention of delirium in allogeneic hematopoietic stem cell transplantationZev M Nakamura, Allison M Deal, Donald L Rosenstein, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2005
Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignanciesDon A Gabriel, Thomas C Shea, Jonathan S Serody, et al.
Cancer|June 29, 2016
Statewide geographic variation in outcomes for adults with acute myeloid leukemia in North CarolinaAshley T Freeman, Anne-Marie Meyer, Andrew B Smitherman, et al.
Leukemia & Lymphoma|August 5, 2011
A phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphomaAnne W Beaven, Thomas C Shea, Dominic T Moore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD developmentYuri Fedoriw, T Danielle Samulski, Allison M Deal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Influence of Treating Facility, Provider Volume, and Patient-Sharing on Survival of Patients With Multiple MyelomaAshley T Freeman, May Kuo, Lei Zhou, et al.
Clinical Therapeutics|October 25, 2016
Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/LPearlie P Chong, David van Duin, Ananta Bangdiwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation settingPatrick J Stiff, Christos Emmanouilides, William I Bensinger, et al.
Pathogens & Immunity|December 23, 2016
Increasing Rates of Fluoroquinolone Resistance in <i>Escherichia coli</i> Isolated From the Blood and Urine of Patients with Hematologic Malignancies and Stem Cell Transplant RecipientsChristopher G Hauck, Pearlie P Chong, Melissa B Miller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 24, 2020
Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantationZev M Nakamura, Allison M Deal, Donald L Rosenstein, et al.
Contemporary Clinical Trials|July 4, 2020
Design of a randomized placebo controlled trial of high dose intravenous thiamine for the prevention of delirium in allogeneic hematopoietic stem cell transplantationZev M Nakamura, Allison M Deal, Donald L Rosenstein, et al.
Pageof 8